About Abattis Bioceuticals Corp.
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of producing, licensing and marketing proprietary ingredients and bio-similar compounds for use in Pharmaceuticals, Nutraceutical, Cosmetic and Animal Nutrition markets. The Company also has a deep pipeline of proprietary products ready for sale in high growth areas of Functional Foods and Supplements business. For more information, visit the Companys website atwww.abattis.com.
PurGenesisis a privately-held, leading Canadian Botanical Pharmaceutical Company that uses novel therapeutic approaches to develop highly promising therapies for significant markets with unmet medical needs. The company is developing novel botanical therapies to treat human inflammatory diseases.PurGenesislead product is PUR0110, a new investigational botanical drug product that incorporates proprietary, extraction processes of a supra-molecular complex with strong anti-inflammatory effects with applications in multiple therapeutic areas. PUR0110 is currently in Phase 2 clinical development for the treatment of Mild to Moderate Ulcerative Colitis and Mild to Moderate psoriasis. The company is also developing anti-aging and sun care products for thecosmeceuticalmarket. For more information, visit the Company`s website atwww.purgenesis.com.